COMP <GO>
MOBI vs EMBC // EV/EBITDA & P/E VALUATION
Mobia Medical Inc. (NASDAQ) VS. Embecta Corp. (NASDAQ) • 15-METRIC TALLY: MOBI 2
— EMBC 1
■ METRIC PARITY
LAST: $11.27 (-4.41%) • MKT CAP: $375.2M
valuation
—
LAST: $6.56 (+1.55%) • MKT CAP: $371.7M
valuation
6.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MOBI VS. EMBC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MOBI | EMBC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 62.60% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 35.50% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 6.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | 22.40% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 8.80% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -3.80% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 9.42% | -9.42 | EMBC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 7/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.1 | 52.2 | +3.95 | MOBI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 3.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $375.2M | $371.7M | $3.5M | MOBI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MOBI REV | EMBC REV | MOBI GROSS % | EMBC GROSS % | MOBI FCF | EMBC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $1.08B | — | 62.6% | — | $182.4M |
| FY 2024 | — | $1.12B | — | 65.5% | — | $19.9M |
| FY 2023 | — | $1.12B | — | — | — | $67.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MOBI // BETA —
EMBC // BETA —